...
首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Early validation study of 64-slice multidetector computed tomography for the assessment of myocardial viability and the prediction of left ventricular remodelling after acute myocardial infarction.
【24h】

Early validation study of 64-slice multidetector computed tomography for the assessment of myocardial viability and the prediction of left ventricular remodelling after acute myocardial infarction.

机译:急性心肌梗死后64层多层螺旋计算机断层扫描技术评估心肌生存力和预测左心室重构的早期验证研究。

获取原文
获取原文并翻译 | 示例

摘要

AIMS: We aim to validate the ability of multidetector computed tomography (MDCT) for assessing myocardial viability and predicting left ventricular (LV) remodelling after acute myocardial infarction (AMI). METHODS AND RESULTS: In 52 consecutive patients with first AMI, 64-slice MDCT without iodine re-injection was performed immediately following coronary stenting. Electrocardiogram-gated thallium-201 single-photon emission tomography was performed using QGS programs within 5 days and 6 months after onset. Among the 52 patients, 18 patients (Group A) showed transmural contrast-delayed enhancement on MDCT images, 20 patients (Group B) showed subendocardial contrast-delayed enhancement, and 14 patients (Group C) had no contrast-delayed enhancement. In the acute phase, peak creatine kinase-MB [497 (189-744), 182 (90-358), 85 (40-204) IU/mL, respectively, P = 0.0004] was significantly higher in Group A, while the incidence of myocardial blush grade 3 (22, 67, 75%, respectively, P = 0.001) and LV ejection fraction (41 +/- 7, 53 +/- 12, 62 +/- 11%, respectively, P < 0.0001) were significantly lower in Group A. During the 6-month period, LV remodelling (P = 0.001) and the number of rehospitalization for heart failure (P = 0.0017) were more significantly observed in Group A. CONCLUSION: Myocardial contrast-delayed enhancement patterns provide promising information regarding myocardial viability, LV remodelling, and prognosis in AMI.
机译:目的:我们的目的是验证急性心肌梗死(AMI)后多能计算机断层扫描(MDCT)评估心肌活力和预测左心室(LV)重塑的能力。方法和结果:在52例连续的首次AMI患者中,在冠状动脉支架置入术后立即进行了64层MDCT,无碘再注射。使用QGS程序在发病后5天和6个月内进行心电门控th 201单光子发射断层扫描。在52例患者中,有18例患者(A组)在MDCT图像上显示了透壁造影剂延迟增强,20例患者(B组)显示了心内膜下造影剂延迟增强,而14例患者(C组)没有造影剂延迟增强。在急性期,A组的峰值肌酸激酶-MB [分别为497(189-744),182(90-358),85(40-204)IU / mL,P = 0.0004]显着更高,而心肌腮红3级的发生率(分别为22、67、75%,P = 0.001)和左室射血分数(分别为41 +/- 7、53 +/- 12、62 +/- 11%,P <0.0001)在6个月期间,A组的左室重塑(P = 0.001)和因心力衰竭而再次住院的人数(P = 0.0017)更为显着。结论:心肌造影剂延迟增强模式提供有关AMI的心肌生存力,左室重塑和预后的有前途的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号